{"id":1220,"date":"2020-05-21T22:54:19","date_gmt":"2020-05-21T22:54:19","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1220"},"modified":"2023-08-29T18:02:05","modified_gmt":"2023-08-29T18:02:05","slug":"antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1220","title":{"rendered":"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d"},"content":{"rendered":"<p>\u751f\u7269\u5236\u836f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=ANP&amp;lang=cn\">Antisense Therapeutics (ASX: ANP)<\/a>\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002<\/p>\n<p>\u8bd5\u9a8c\u7ed3\u679c\u4e5f\u5f97\u5230\u4e86\u4e00\u4e9b\u79d1\u5b66\u5bb6\u3001\u7814\u7a76\u4eba\u5458\u548c\u5176\u4ed6\u4e86\u89e3\u8bd5\u9a8c\u53c2\u6570\u548c\u7ec8\u70b9\u7684\u533b\u5b66\u4e13\u4e1a\u4eba\u58eb\u7684\u53e3\u5934\u652f\u6301\u3002<\/p>\n<p>\u5728\u7b2c2\u671f\u8bd5\u9a8c\u4e2d\uff0c9\u540d\u975e\u5367\u5e8a\u7684DMD\u60a3\u8005\u6bcf\u5468\u76ae\u4e0b\u6ce8\u5c041\u6b21\uff0c\u6301\u7eed24\u5468\u3002<\/p>\n<p>\u603b\u7684\u6765\u8bf4\uff0c\u8be5\u7814\u7a76\u8868\u660e\uff0c\u4f7f\u7528ATL1102\u53ef\u4ee5\u201c\u5728\u4e0d\u540c\u7684\u8fd0\u52a8\u529f\u80fd\u548c\u5f3a\u5ea6\u7684\u6d4b\u91cf\u4e0a\u53d6\u5f97\u4e00\u81f4\u7684\u6539\u5584\u6216\u7a33\u5b9a\u201d\u3002<\/p>\n<p>\u8fd9\u4e00\u6d88\u606f\u610f\u5473\u7740\uff0cATL1102\u53ef\u80fd\u4f1a\u8fdb\u5165\u201c\u5173\u952e\u201d\u9636\u6bb5\u76842b\u8bd5\u9a8c\uff0c\u53ef\u80fd\u5728\u5e74\u5e95\u524d\u542f\u52a8\u5e76\u8fd0\u884c\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u8be5\u516c\u53f8\u8fd8\u8868\u793a\uff0c\u6700\u7ec8\u8bd5\u9a8c\u7ed3\u679c\u4e5f\u8bc1\u5b9e\u4e86\u8be5\u836f\u7269\u5bf9\u8bc4\u4f30\u5176\u6d3b\u6027\u548c\u7597\u6548\u7684\u6b21\u8981\u8bd5\u9a8c\u7ec8\u70b9\u7684\u79ef\u6781\u5f71\u54cd\uff0c\u5305\u62ec\u6d4b\u91cf\u5bf9\u8840\u6db2\u4e2d\u514d\u75ab\u7ec6\u80de\u6570\u91cf\u7684\u5f71\u54cd\u548c\u6d4b\u91cf\u53c2\u4e0e\u8005\u7684\u529f\u80fd\u80fd\u529b\u3002<\/p>\n<p>\u6b64\u5916\uff0cAntisense\u7814\u7a76\u62a5\u544a\u79f0\uff0c\u5bf9\u60a3\u8005\u4e0a\u80a2\u808c\u8089\u7684\u6838\u78c1\u5171\u632f\u8bc4\u4f30\u663e\u793a\uff0c\u8be5\u836f\u5728\u7a33\u5b9a\u524d\u81c2\u808c\u8089\u4e2d\u7684\u8102\u80aa\u6bd4\u4f8b\u65b9\u9762\u5177\u6709\u660e\u663e\u7684\u6709\u76ca\u4f5c\u7528\u3002<\/p>\n<p>Antisense\u7684\u6570\u636e\u663e\u793a\uff0c\u524d\u81c2\u808c\u8089\u4e2d\u7684\u8102\u80aa\u6bd4\u4f8b\u7a33\u5b9a\uff0c\u529f\u80fd\u808c\u8089\u8d28\u91cf\u589e\u52a0\/\u7ef4\u6301\uff0c\u8fd9\u5bf9\u4e8e\u6cbb\u7597\u708e\u75c7\u7684\u836f\u7269\u6765\u8bf4\uff0c\u65e2\u201c\u7a81\u51fa\u201d\u53c8\u201c\u51fa\u4e4e\u610f\u6599\u201d\u3002<\/p>\n<p>\u7814\u7a76\u5458\u535a\u58ebValeria Ricotti\u4ece\u82f1\u56fd\u4f26\u6566\u5927\u5b66\u5b66\u9662\u513f\u7ae5\u5065\u5eb7\u7814\u7a76\u6240Great Ormond Street Institute of Child Health University College London\u89e3\u91ca\u8bf4,\u6839\u636e\u6838\u78c1\u5171\u632f\u6570\u636e,\u89c2\u5bdf\u5230\u7a33\u5b9a\u7684\u8102\u80aa\u767e\u5206\u6bd4\u5206\u6570ATL1102\u6cbb\u7597\u201c\u4e0d\u4f1a\u9884\u671f\u7684\u81ea\u7136\u75c5\u7a0bDMD\u5373\u4f7f\u5728\u76ae\u8d28\u7c7b\u56fa\u9187\u6cbb\u7597\u201d\u3002<\/p>\n<p>\u5979\u8bf4:\u201c\u6b64\u5916\uff0c\u8102\u80aa\u6bd4\u4f8b\u7684\u7a33\u5b9a\u4e0e\u89c2\u5bdf\u5230\u7684\u5269\u4f59\u808c\u8089\u9762\u79ef\u7684\u7ef4\u6301\/\u589e\u52a0\u76f8\u7ed3\u5408\uff0c\u63d0\u793aATL1102\u7684\u6548\u679c\u53ef\u4ee5\u4fdd\u6301\u53ef\u6536\u7f29\u7684\u808c\u8089\u8d28\u91cf\u3002\u201d<\/p>\n<p>\u201c\u8be5\u7814\u7a76\u8fbe\u5230\u4e86\u5176\u4e3b\u8981\u7ec8\u70b9\uff0c\u663e\u793aATL1102\u662f\u5b89\u5168\u7684\u548c\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u6ca1\u6709\u4e25\u91cd\u7684\u4e0d\u826f\u4e8b\u4ef6\u7684\u62a5\u544a\uff0c\u4e5f\u6ca1\u6709\u53c2\u4e0e\u8005\u9000\u51fa\u7814\u7a76\u3002\u56e0\u4e3a\u5f88\u5c11\u6709\u6cbb\u7597\u65b9\u6848\u9488\u5bf9\u4e0d\u518d\u80fd\u884c\u8d70\u7684\u675c\u6c0f\u7537\u5b69,\u80fd\u4f7f\u5b69\u5b50\u4eec\u53c2\u52a0\u4e34\u5e8a\u8bd5\u9a8c\u6211\u611f\u5230\u5f88\u6b23\u6170,\u6211\u5341\u5206\u671f\u5f85\u7814\u7a76\u7684\u7ed3\u679c,\u201d\u9996\u5e2d\u7814\u7a76\u5458Ian Woodcock\u535a\u58eb\u8bf4ATL1102\u7b2c\u4e8c\u9636\u6bb5\u6a21\u5f0f\u8bd5\u9a8c\u3002<\/p>\n<h2>\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7<\/h2>\n<p>DMD\u662f\u4e00\u79cd\u4e25\u91cd\u7c7b\u578b\u7684\u808c\u8089\u840e\u7f29\u75c7\uff0c\u5f00\u59cb\u4e8e\u513f\u7ae5\u65e9\u671f\uff0c\u5e76\u9010\u6e10\u6076\u5316\uff0c\u901a\u8fc7\u6301\u7eed\u524a\u5f31\u808c\u8089\u7ec4\u7ec7\u3002\u6839\u636e\u5bf9\u8fd9\u79cd\u7f55\u89c1\u7684\u9057\u4f20\u6027\u75be\u75c5\u7684\u79d1\u5b66\u7814\u7a76\uff0c\u51e0\u4e4e\u5b8c\u5168\u7684\u808c\u8089\u635f\u5931\u901a\u5e38\u9996\u5148\u53d1\u751f\u5728\u5927\u817f\u548c\u9aa8\u76c6\uff0c\u7136\u540e\u662f\u624b\u81c2\u3002<\/p>\n<p>\u76ee\u524d\uff0c\u5168\u7403\u7ea6\u670930\u4e07\u4eba\u60a3\u6709\u8fd9\u79cd\u75be\u75c5\uff0c\u4f46\u6ca1\u6709\u5df2\u77e5\u7684\u6cbb\u6108\u65b9\u6cd5\u6216\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\u5c3d\u7ba1\u7f3a\u4e4f\u957f\u671f\u7684\u6cbb\u7597\u65b9\u6cd5\uff0c\u4f46\u60a3\u8005\u7ecf\u5e38\u88ab\u8981\u6c42\u4f7f\u7528\u76ae\u8d28\u7c7b\u56fa\u9187\u6fc0\u7d20\u6765\u5e2e\u52a9\u7f13\u89e3\u77ed\u671f\u7684\u5916\u90e8\u75c7\u72b6\u3002<\/p>\n<p>ataluren\u7b49\u73b0\u6709\u836f\u7269\u5df2\u83b7\u51c6\u5728\u6b27\u76df\u6709\u9650\u4f7f\u7528\uff0c\u800c\u88ab\u79f0\u4e3a\u201c\u53cd\u4e49\u5be1\u6838\u201d\u7684golodirsen\u53bb\u5e74\u5df2\u83b7\u51c6\u5728\u7f8e\u56fd\u4f7f\u7528\u3002<\/p>\n<h2>\u4e0b\u4e00\u4e2a\u8bd5\u9a8c\u9636\u6bb5<\/h2>\n<p>\u5728DMD\u8bd5\u9a8c\u53d6\u5f97\u4ee4\u4eba\u6ee1\u610f\u7684\u7ed3\u679c\u540e\uff0cAntisense\u8868\u793a\uff0c\u5b83\u73b0\u5728\u6253\u7b97\u5c06ATL1102\u63d0\u4ea4\u7ed92b\u9636\u6bb5\u7684\u8bd5\u9a8c\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u8868\u793a\uff0c\u5df2\u7ecf\u4e0e\u4e09\u5bb6\u6b27\u6d32\u76d1\u7ba1\u673a\u6784\u4e3e\u884c\u4e86\u79d1\u5b66\u54a8\u8be2\u4f1a\u8bae\uff0c\u6bcf\u4e00\u5bb6\u673a\u6784\u90fd\u786e\u8ba4\u666e\u904d\u63a5\u53d7\u62df\u8bae\u7684\u8bd5\u9a8c\u7597\u6548\u7ec8\u70b9\u3001\u5b89\u5168\u76d1\u6d4b\u8ba1\u5212\u300112\u4e2a\u6708\u7684\u7ed9\u836f\u65f6\u95f4\u4ee5\u53ca\u66f4\u9ad8\u5242\u91cf\u7684\u4f7f\u7528\u3002<\/p>\n<p>\u5c31\u76ee\u524d\u60c5\u51b5\u6765\u770b\uff0c\u8fd9\u5bb6\u751f\u7269\u5236\u836f\u516c\u53f8\u5df2\u7ecf\u5411\u6b27\u6d32\u836f\u7269\u7ba1\u7406\u5c40\u63d0\u4ea4\u4e86\u4e00\u4efd\u79d1\u5b66\u5efa\u8bae\uff0c\u5176\u8bc4\u4f30\u7ed3\u679c\u5c06\u5728\u201c\u5e74\u4e2d\u201d\u516c\u5e03\u3002\u4e00\u65e6\u6536\u5230\u56de\u5e94\u5e76\u8fdb\u884c\u8bc4\u4f30\uff0cAntisense\u8868\u793a\uff0c\u5b83\u5c06\u5728\u6b27\u6d32\u548c\u82f1\u56fd\u51c6\u5907\u5e76\u63d0\u4ea4\u4e00\u4efd\u5b8c\u6574\u7684\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u8fd8\u5728\u79ef\u6781\u51c6\u5907\u63d0\u4ea4\u7f8e\u56fd\u548c\u6b27\u76dfATL1102\u5b64\u513f\u836f\u6307\u5b9a\u7533\u8bf7\u3002<\/p>\n<p>\u5728\u5bf9ATL1102\u6297\u708e\u4f5c\u7528\u7684\u89c2\u5bdf\u7ed3\u679c\u7684\u9f13\u821e\u4e0b\uff0c\u53cd\u4e49\u516c\u53f8\u5ba3\u5e03\uff0c\u5b83\u8fd8\u5c06\u7814\u7a76\u5176\u4ed6\u6f5c\u5728\u7684\u75be\u75c5\uff0c\u5305\u62ec\u90a3\u4e9b\u7528\u76ae\u8d28\u7c7b\u56fa\u9187\u4e0d\u80fd\u5145\u5206\u63a7\u5236\u7684\u75be\u75c5\uff0c\u5982\u5176\u4ed6\u808c\u8425\u517b\u4e0d\u826f\u548c\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u3002<\/p>\n<p>Antisense Therapeutics\u7684\u9996\u5e2d\u6267\u884c\u5b98Mark Diamond\u8bf4:\u201c\u6211\u4eec\u7684\u91cd\u70b9\u662f\u7ee7\u7eed\u89c4\u5212\uff0c\u5e76\u6709\u6761\u4e0d\u7d0a\u5730\u3001\u6709\u6548\u5730\u63a8\u52a8\u6211\u4eec\u7684DMD\u9879\u76ee\u901a\u8fc7\u6b27\u6d32\u7684IIb\u9636\u6bb5\u3002\u201d<\/p>\n<p>\u201c\u968f\u7740\u6211\u4eec\u4ece\u76d1\u7ba1\u7a0b\u5e8f\u4e2d\u83b7\u5f97\u5173\u4e8e\u4e0b\u4e00\u4e2a\u8bd5\u9a8c\u53c2\u6570\u7684\u8fdb\u4e00\u6b65\u786e\u5b9a\u6027\uff0c\u8fd9\u53ef\u80fd\u4f1a\u5bfc\u81f4\u65e9\u671f\u5e02\u573a\u6279\u51c6\uff0c\u6211\u4eec\u5c06\u8bc4\u4f30\u8d44\u91d1\u548c\u8bd5\u9a8c\u7ba1\u7406\u65b9\u6848\uff0c\u5e76\u57282b\u9636\u6bb5\u5f00\u59cb\u524d\u4e0e\u611f\u5174\u8da3\u7684\u6f5c\u5728\u5408\u4f5c\u4f19\u4f34\u8fdb\u884c\u8ba8\u8bba\u3002\u201d\u8fd9\u5c06\u4f7f\u8be5\u516c\u53f8\u80fd\u591f\u8003\u8651\u6700\u6709\u5229\u7684\u65b9\u5f0f\uff0c\u81ea\u884c\u6216\u4e0e\u5408\u4f5c\u4f19\u4f34\u4e00\u8d77\u8fdb\u884c\u8fd9\u4e00\u5173\u952e\u8bd5\u9a8c\uff0c\u201dDiamond\u8868\u793a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002 \u8bd5\u9a8c\u7ed3\u679c\u4e5f\u5f97\u5230\u4e86\u4e00\u4e9b\u79d1\u5b66\u5bb6\u3001\u7814\u7a76\u4eba\u5458\u548c\u5176\u4ed6\u4e86\u89e3\u8bd5\u9a8c\u53c2\u6570\u548c\u7ec8\u70b9\u7684\u533b\u5b66\u4e13\u4e1a\u4eba\u58eb\u7684\u53e3\u5934\u652f\u6301\u3002 \u5728\u7b2c2\u671f\u8bd5\u9a8c\u4e2d\uff0c9\u540d\u975e\u5367\u5e8a\u7684DMD\u60a3\u8005\u6bcf\u5468\u76ae\u4e0b\u6ce8\u5c041\u6b21\uff0c\u6301\u7eed24\u5468\u3002 \u603b\u7684\u6765\u8bf4\uff0c\u8be5\u7814\u7a76\u8868\u660e\uff0c\u4f7f\u7528ATL1102\u53ef\u4ee5\u201c\u5728\u4e0d\u540c\u7684\u8fd0\u52a8\u529f\u80fd\u548c\u5f3a\u5ea6\u7684\u6d4b\u91cf\u4e0a\u53d6\u5f97\u4e00\u81f4\u7684\u6539\u5584\u6216\u7a33\u5b9a\u201d\u3002 \u8fd9\u4e00\u6d88\u606f\u610f\u5473\u7740\uff0cATL1102\u53ef\u80fd\u4f1a\u8fdb\u5165\u201c\u5173\u952e\u201d\u9636\u6bb5\u76842b\u8bd5\u9a8c\uff0c\u53ef\u80fd\u5728\u5e74\u5e95\u524d\u542f\u52a8\u5e76\u8fd0\u884c\u3002 \u6b64\u5916\uff0c\u8be5\u516c\u53f8\u8fd8\u8868\u793a\uff0c\u6700\u7ec8\u8bd5\u9a8c\u7ed3\u679c\u4e5f\u8bc1\u5b9e\u4e86\u8be5\u836f\u7269\u5bf9\u8bc4\u4f30\u5176\u6d3b\u6027\u548c\u7597\u6548\u7684\u6b21\u8981\u8bd5\u9a8c\u7ec8\u70b9\u7684\u79ef\u6781\u5f71\u54cd\uff0c\u5305\u62ec\u6d4b\u91cf\u5bf9\u8840\u6db2\u4e2d\u514d\u75ab\u7ec6\u80de\u6570\u91cf\u7684\u5f71\u54cd\u548c\u6d4b\u91cf\u53c2\u4e0e\u8005\u7684\u529f\u80fd\u80fd\u529b\u3002 \u6b64\u5916\uff0cAntisense\u7814\u7a76\u62a5\u544a\u79f0\uff0c\u5bf9\u60a3\u8005\u4e0a\u80a2\u808c\u8089\u7684\u6838\u78c1\u5171\u632f\u8bc4\u4f30\u663e\u793a\uff0c\u8be5\u836f\u5728\u7a33\u5b9a\u524d\u81c2\u808c\u8089\u4e2d\u7684\u8102\u80aa\u6bd4\u4f8b\u65b9\u9762\u5177\u6709\u660e\u663e\u7684\u6709\u76ca\u4f5c\u7528\u3002 Antisense\u7684\u6570\u636e\u663e\u793a\uff0c\u524d\u81c2\u808c\u8089\u4e2d\u7684\u8102\u80aa\u6bd4\u4f8b\u7a33\u5b9a\uff0c\u529f\u80fd\u808c\u8089\u8d28\u91cf\u589e\u52a0\/\u7ef4\u6301\uff0c\u8fd9\u5bf9\u4e8e\u6cbb\u7597\u708e\u75c7\u7684\u836f\u7269\u6765\u8bf4\uff0c\u65e2\u201c\u7a81\u51fa\u201d\u53c8\u201c\u51fa\u4e4e\u610f\u6599\u201d\u3002 \u7814\u7a76\u5458\u535a\u58ebValeria Ricotti\u4ece\u82f1\u56fd\u4f26\u6566\u5927\u5b66\u5b66\u9662\u513f\u7ae5\u5065\u5eb7\u7814\u7a76\u6240Great Ormond Street Institute of Child Health University College London\u89e3\u91ca\u8bf4,\u6839\u636e\u6838\u78c1\u5171\u632f\u6570\u636e,\u89c2\u5bdf\u5230\u7a33\u5b9a\u7684\u8102\u80aa\u767e\u5206\u6bd4\u5206\u6570ATL1102\u6cbb\u7597\u201c\u4e0d\u4f1a\u9884\u671f\u7684\u81ea\u7136\u75c5\u7a0bDMD\u5373\u4f7f\u5728\u76ae\u8d28\u7c7b\u56fa\u9187\u6cbb\u7597\u201d\u3002 \u5979\u8bf4:\u201c\u6b64\u5916\uff0c\u8102\u80aa\u6bd4\u4f8b\u7684\u7a33\u5b9a\u4e0e\u89c2\u5bdf\u5230\u7684\u5269\u4f59\u808c\u8089\u9762\u79ef\u7684\u7ef4\u6301\/\u589e\u52a0\u76f8\u7ed3\u5408\uff0c\u63d0\u793aATL1102\u7684\u6548\u679c\u53ef\u4ee5\u4fdd\u6301\u53ef\u6536\u7f29\u7684\u808c\u8089\u8d28\u91cf\u3002\u201d \u201c\u8be5\u7814\u7a76\u8fbe\u5230\u4e86\u5176\u4e3b\u8981\u7ec8\u70b9\uff0c\u663e\u793aATL1102\u662f\u5b89\u5168\u7684\u548c\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u6ca1\u6709\u4e25\u91cd\u7684\u4e0d\u826f\u4e8b\u4ef6\u7684\u62a5\u544a\uff0c\u4e5f\u6ca1\u6709\u53c2\u4e0e\u8005\u9000\u51fa\u7814\u7a76\u3002\u56e0\u4e3a\u5f88\u5c11\u6709\u6cbb\u7597\u65b9\u6848\u9488\u5bf9\u4e0d\u518d\u80fd\u884c\u8d70\u7684\u675c\u6c0f\u7537\u5b69,\u80fd\u4f7f\u5b69\u5b50\u4eec\u53c2\u52a0\u4e34\u5e8a\u8bd5\u9a8c\u6211\u611f\u5230\u5f88\u6b23\u6170,\u6211\u5341\u5206\u671f\u5f85\u7814\u7a76\u7684\u7ed3\u679c,\u201d\u9996\u5e2d\u7814\u7a76\u5458Ian Woodcock\u535a\u58eb\u8bf4ATL1102\u7b2c\u4e8c\u9636\u6bb5\u6a21\u5f0f\u8bd5\u9a8c\u3002 \u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7 DMD\u662f\u4e00\u79cd\u4e25\u91cd\u7c7b\u578b\u7684\u808c\u8089\u840e\u7f29\u75c7\uff0c\u5f00\u59cb\u4e8e\u513f\u7ae5\u65e9\u671f\uff0c\u5e76\u9010\u6e10\u6076\u5316\uff0c\u901a\u8fc7\u6301\u7eed\u524a\u5f31\u808c\u8089\u7ec4\u7ec7\u3002\u6839\u636e\u5bf9\u8fd9\u79cd\u7f55\u89c1\u7684\u9057\u4f20\u6027\u75be\u75c5\u7684\u79d1\u5b66\u7814\u7a76\uff0c\u51e0\u4e4e\u5b8c\u5168\u7684\u808c\u8089\u635f\u5931\u901a\u5e38\u9996\u5148\u53d1\u751f\u5728\u5927\u817f\u548c\u9aa8\u76c6\uff0c\u7136\u540e\u662f\u624b\u81c2\u3002 \u76ee\u524d\uff0c\u5168\u7403\u7ea6\u670930\u4e07\u4eba\u60a3\u6709\u8fd9\u79cd\u75be\u75c5\uff0c\u4f46\u6ca1\u6709\u5df2\u77e5\u7684\u6cbb\u6108\u65b9\u6cd5\u6216\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\u5c3d\u7ba1\u7f3a\u4e4f\u957f\u671f\u7684\u6cbb\u7597\u65b9\u6cd5\uff0c\u4f46\u60a3\u8005\u7ecf\u5e38\u88ab\u8981\u6c42\u4f7f\u7528\u76ae\u8d28\u7c7b\u56fa\u9187\u6fc0\u7d20\u6765\u5e2e\u52a9\u7f13\u89e3\u77ed\u671f\u7684\u5916\u90e8\u75c7\u72b6\u3002 ataluren\u7b49\u73b0\u6709\u836f\u7269\u5df2\u83b7\u51c6\u5728\u6b27\u76df\u6709\u9650\u4f7f\u7528\uff0c\u800c\u88ab\u79f0\u4e3a\u201c\u53cd\u4e49\u5be1\u6838\u201d\u7684golodirsen\u53bb\u5e74\u5df2\u83b7\u51c6\u5728\u7f8e\u56fd\u4f7f\u7528\u3002 \u4e0b\u4e00\u4e2a\u8bd5\u9a8c\u9636\u6bb5 \u5728DMD\u8bd5\u9a8c\u53d6\u5f97\u4ee4\u4eba\u6ee1\u610f\u7684\u7ed3\u679c\u540e\uff0cAntisense\u8868\u793a\uff0c\u5b83\u73b0\u5728\u6253\u7b97\u5c06ATL1102\u63d0\u4ea4\u7ed92b\u9636\u6bb5\u7684\u8bd5\u9a8c\u3002 \u8be5\u516c\u53f8\u8868\u793a\uff0c\u5df2\u7ecf\u4e0e\u4e09\u5bb6\u6b27\u6d32\u76d1\u7ba1\u673a\u6784\u4e3e\u884c\u4e86\u79d1\u5b66\u54a8\u8be2\u4f1a\u8bae\uff0c\u6bcf\u4e00\u5bb6\u673a\u6784\u90fd\u786e\u8ba4\u666e\u904d\u63a5\u53d7\u62df\u8bae\u7684\u8bd5\u9a8c\u7597\u6548\u7ec8\u70b9\u3001\u5b89\u5168\u76d1\u6d4b\u8ba1\u5212\u300112\u4e2a\u6708\u7684\u7ed9\u836f\u65f6\u95f4\u4ee5\u53ca\u66f4\u9ad8\u5242\u91cf\u7684\u4f7f\u7528\u3002 \u5c31\u76ee\u524d\u60c5\u51b5\u6765\u770b\uff0c\u8fd9\u5bb6\u751f\u7269\u5236\u836f\u516c\u53f8\u5df2\u7ecf\u5411\u6b27\u6d32\u836f\u7269\u7ba1\u7406\u5c40\u63d0\u4ea4\u4e86\u4e00\u4efd\u79d1\u5b66\u5efa\u8bae\uff0c\u5176\u8bc4\u4f30\u7ed3\u679c\u5c06\u5728\u201c\u5e74\u4e2d\u201d\u516c\u5e03\u3002\u4e00\u65e6\u6536\u5230\u56de\u5e94\u5e76\u8fdb\u884c\u8bc4\u4f30\uff0cAntisense\u8868\u793a\uff0c\u5b83\u5c06\u5728\u6b27\u6d32\u548c\u82f1\u56fd\u51c6\u5907\u5e76\u63d0\u4ea4\u4e00\u4efd\u5b8c\u6574\u7684\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u3002 \u8be5\u516c\u53f8\u8fd8\u5728\u79ef\u6781\u51c6\u5907\u63d0\u4ea4\u7f8e\u56fd\u548c\u6b27\u76dfATL1102\u5b64\u513f\u836f\u6307\u5b9a\u7533\u8bf7\u3002 \u5728\u5bf9ATL1102\u6297\u708e\u4f5c\u7528\u7684\u89c2\u5bdf\u7ed3\u679c\u7684\u9f13\u821e\u4e0b\uff0c\u53cd\u4e49\u516c\u53f8\u5ba3\u5e03\uff0c\u5b83\u8fd8\u5c06\u7814\u7a76\u5176\u4ed6\u6f5c\u5728\u7684\u75be\u75c5\uff0c\u5305\u62ec\u90a3\u4e9b\u7528\u76ae\u8d28\u7c7b\u56fa\u9187\u4e0d\u80fd\u5145\u5206\u63a7\u5236\u7684\u75be\u75c5\uff0c\u5982\u5176\u4ed6\u808c\u8425\u517b\u4e0d\u826f\u548c\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u3002 Antisense Therapeutics\u7684\u9996\u5e2d\u6267\u884c\u5b98Mark Diamond\u8bf4:\u201c\u6211\u4eec\u7684\u91cd\u70b9\u662f\u7ee7\u7eed\u89c4\u5212\uff0c\u5e76\u6709\u6761\u4e0d\u7d0a\u5730\u3001\u6709\u6548\u5730\u63a8\u52a8\u6211\u4eec\u7684DMD\u9879\u76ee\u901a\u8fc7\u6b27\u6d32\u7684IIb\u9636\u6bb5\u3002\u201d \u201c\u968f\u7740\u6211\u4eec\u4ece\u76d1\u7ba1\u7a0b\u5e8f\u4e2d\u83b7\u5f97\u5173\u4e8e\u4e0b\u4e00\u4e2a\u8bd5\u9a8c\u53c2\u6570\u7684\u8fdb\u4e00\u6b65\u786e\u5b9a\u6027\uff0c\u8fd9\u53ef\u80fd\u4f1a\u5bfc\u81f4\u65e9\u671f\u5e02\u573a\u6279\u51c6\uff0c\u6211\u4eec\u5c06\u8bc4\u4f30\u8d44\u91d1\u548c\u8bd5\u9a8c\u7ba1\u7406\u65b9\u6848\uff0c\u5e76\u57282b\u9636\u6bb5\u5f00\u59cb\u524d\u4e0e\u611f\u5174\u8da3\u7684\u6f5c\u5728\u5408\u4f5c\u4f19\u4f34\u8fdb\u884c\u8ba8\u8bba\u3002\u201d\u8fd9\u5c06\u4f7f\u8be5\u516c\u53f8\u80fd\u591f\u8003\u8651\u6700\u6709\u5229\u7684\u65b9\u5f0f\uff0c\u81ea\u884c\u6216\u4e0e\u5408\u4f5c\u4f19\u4f34\u4e00\u8d77\u8fdb\u884c\u8fd9\u4e00\u5173\u952e\u8bd5\u9a8c\uff0c\u201dDiamond\u8868\u793a\u3002<\/p>\n","protected":false},"author":5,"featured_media":7947,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[272],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-21T22:54:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Antisense-Therapeutics-ASX-ANP-Duchenne-Muscular-Dystrophy-drug-Phase-2-trial-ATL1102.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d\" \/>\n<meta name=\"twitter:description\" content=\"\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Antisense-Therapeutics-ASX-ANP-Duchenne-Muscular-Dystrophy-drug-Phase-2-trial-ATL1102.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/\",\"name\":\"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-05-21T22:54:19+00:00\",\"dateModified\":\"2023-08-29T18:02:05+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d","description":"\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d","og_description":"\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/","og_site_name":"smallcapsCN","article_published_time":"2020-05-21T22:54:19+00:00","article_modified_time":"2023-08-29T18:02:05+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Antisense-Therapeutics-ASX-ANP-Duchenne-Muscular-Dystrophy-drug-Phase-2-trial-ATL1102.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d","twitter_description":"\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/Antisense-Therapeutics-ASX-ANP-Duchenne-Muscular-Dystrophy-drug-Phase-2-trial-ATL1102.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/","url":"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/","name":"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-05-21T22:54:19+00:00","dateModified":"2023-08-29T18:02:05+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u751f\u7269\u5236\u836f\u516c\u53f8Antisense Therapeutics (ASX: ANP)\u5ba3\u5e03\u5176\u9488\u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7(DMD)\u7684\u514d\u75ab\u8c03\u8282\u7597\u6cd5ATL1102\u8fbe\u5230\u4e86\u8981\u6c42\u7684\u5b89\u5168\u6807\u51c6\uff0c\u5e76\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53d6\u5f97\u4e86\u201c\u5f3a\u70c8\u7684\u521d\u59cb\u7597\u6548\u201d\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/antisense-therapeutics-strong-efficacy-duchenne-muscular-dystrophy-drug-phase-2-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Antisense Therapeutics\u62a5\u544a\u4e86\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u836f\u7269\u5728\u7b2c2\u9636\u6bb5\u8bd5\u9a8c\u4e2d\u7684\u201c\u5f3a\u5927\u7684\u521d\u6b65\u7597\u6548\u201d"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1220"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1220"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1220\/revisions"}],"predecessor-version":[{"id":7946,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1220\/revisions\/7946"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/7947"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}